{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:43:28Z","timestamp":1792691008348,"version":"4.5.0"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010731","name":"Faculty of Medicine, Chiang Mai University","doi-asserted-by":"publisher","award":["091\/2568"],"award-info":[{"award-number":["091\/2568"]}],"id":[{"id":"10.13039\/501100010731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"\n Background<\/jats:title>\n Asprosin a glucogenic adipokine associated with insulin resistance, has been found to be elevated in the plasma of women with gestational diabetes mellitus (GDM). Emerging evidence indicates that it can serve as a promising biomarker for the diagnosis of GDM during the second trimester. However, its utility in the first trimester has not yet been investigated. Therefore, the present study aimed to establish first-trimester reference ranges for plasma asprosin and to evaluate its predictive performance for the subsequent development of GDM.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n In this prospective cohort study, low-risk women with singleton pregnancies at 10\u201314 weeks of gestation were consecutively enrolled. Participants with pregestational diabetes were excluded. Baseline clinical characteristics were documented, and blood samples were obtained for the measurement of plasma asprosin concentrations. The diagnosis of GDM at 24\u201328 weeks of gestation was established using the two-step screening approach.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among the 302 participants, 98 (32.5%) developed GDM. Asprosin concentrations did not differ significantly across gestational ages between 10 and 14 weeks. However, asprosin levels increased significantly with maternal BMI (p\u2009<\u20090.001), demonstrating a quadratic relationship. A first-trimester reference range for plasma asprosin was established. Nevertheless, first-trimester asprosin showed poor predictive performance for subsequent GDM (AUC\u2009=\u20090.516), whereas maternal BMI and age showed modest predictive ability.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n First, a reference range for first-trimester asprosin was established, which may serve as a valuable benchmark for future investigations examining various aspects of diabetes in pregnancy. Second, first-trimester asprosin concentrations did not discriminate between women who subsequently developed GDM and those who did not.<\/jats:p>\n <\/jats:sec>","DOI":"10.1371\/journal.pone.0359945","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:23:42Z","timestamp":1792689822000},"page":"e0359945","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["First-trimester plasma asprosin and its association with gestational diabetes mellitus: A prospective cohort study"],"prefix":"10.1371","volume":"21","author":[{"given":"Sathaphone","family":"Inthavong","sequence":"first","affiliation":[{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Department of Obstetrics and Gynecology; Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4176-3501","authenticated-orcid":true,"given":"Phudit","family":"Jatavan","sequence":"additional","affiliation":[{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Department of Obstetrics and Gynecology; Faculty of Medicine"]},{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Fetal Center, Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirinart","family":"Kumfu","sequence":"additional","affiliation":[{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Department of Physiology, Faculty of Medicine"]},{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Center of Excellence in Cardiac Electrophysiology Research"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Chattipakorn","sequence":"additional","affiliation":[{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Department of Physiology, Faculty of Medicine"]},{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Center of Excellence in Cardiac Electrophysiology Research"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3389-6478","authenticated-orcid":true,"given":"Theera","family":"Tongsong","sequence":"additional","affiliation":[{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Department of Obstetrics and Gynecology; Faculty of Medicine"]},{"name":"Chiang Mai University","place":["Chiang Mai, Thailand"],"department":["Fetal Center, Faculty of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"pone.0359945.ref001","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"pone.0359945.ref002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1471-0528.2009.02486.x","article-title":"Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index","volume":"117","author":"HAPO Study Cooperative Research Group","year":"2010","journal-title":"BJOG"},{"issue":"6","key":"pone.0359945.ref003","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00125-019-4840-2","article-title":"Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis","volume":"62","author":"CK Kramer","year":"2019","journal-title":"Diabetologia"},{"issue":"3","key":"pone.0359945.ref004","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Panel International Association of Diabetes and Pregnancy Study Groups Consensus","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"pone.0359945.ref005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cell.2016.02.063","article-title":"Asprosin, a Fasting-Induced Glucogenic Protein Hormone","volume":"165","author":"C Romere","year":"2016","journal-title":"Cell"},{"issue":"12","key":"pone.0359945.ref006","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nm.4432","article-title":"Asprosin is a centrally acting orexigenic hormone","volume":"23","author":"C Duerrschmid","year":"2017","journal-title":"Nat Med"},{"key":"pone.0359945.ref007","article-title":"Pathophysiological insights into asprosin: an emerging adipokine in reproductive health","author":"S Khan","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"pone.0359945.ref008","doi-asserted-by":"crossref","first-page":"103095","DOI":"10.1016\/j.dsx.2024.103095","article-title":"Asprosin levels in patients with type 2 diabetes mellitus, metabolic syndrome and obesity: A systematic review and meta-analysis","volume":"18","author":"JR Ulloque-Badaracco","year":"2024","journal-title":"Diabetes Metab Syndr"},{"key":"pone.0359945.ref009","article-title":"Role of New Biomarkers in the Early Diagnosis of Gestational Diabetes: A Mini Review","author":"ZI Sonkaya","year":"2025","journal-title":"Curr Top Med Chem"},{"key":"pone.0359945.ref010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.placenta.2020.02.004","article-title":"Continuous elevation of plasma asprosin in pregnant women complicated with gestational diabetes mellitus: A nested case-control study","volume":"93","author":"L Zhong","year":"2020","journal-title":"Placenta"},{"key":"pone.0359945.ref011","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2147\/DMSO.S424651","article-title":"Association Between Plasma Asprosin Levels and Gestational Diabetes Mellitus","volume":"16","author":"\u0130B Boz","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"9","key":"pone.0359945.ref012","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/healthcare11091315","article-title":"Trends in the Prevalence of Diabetes Mellitus in Pregnancy during the Past Two Decades in Northern Thailand","volume":"11","author":"P Jatavan","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"3","key":"pone.0359945.ref013","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0069","article-title":"Correlation of metabolic characteristics with maternal, fetal and placental asprosin in human pregnancy","volume":"11","author":"T Hoffmann","year":"2022","journal-title":"Endocr Connect"},{"issue":"1","key":"pone.0359945.ref014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ijo.2011.51","article-title":"Body shape by 3-D photonic scanning in Thai and UK adults: comparison of national sizing surveys","volume":"36","author":"JCK Wells","year":"2012","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"pone.0359945.ref015","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1017\/S0007114511001681","article-title":"Ethnic differences in the relationship between body mass index and percentage body fat among Asian children from different backgrounds","volume":"106","author":"A Liu","year":"2011","journal-title":"Br J Nutr"},{"issue":"2","key":"pone.0359945.ref016","doi-asserted-by":"crossref","first-page":"620","DOI":"10.3390\/nu13020620","article-title":"Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature","volume":"13","author":"AI Mazur-Bialy","year":"2021","journal-title":"Nutrients"},{"key":"pone.0359945.ref017","doi-asserted-by":"crossref","first-page":"170132","DOI":"10.1016\/j.peptides.2019.170132","article-title":"Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus","volume":"120","author":"Y Baykus","year":"2019","journal-title":"Peptides"},{"issue":"4","key":"pone.0359945.ref018","article-title":"The Double-Edged Sword of Gestational Insulin Resistance: Navigating Maternal Adaptation and Its Risks for Pregnancy and Offspring Health","volume":"27","author":"R Du","year":"2026","journal-title":"Obes Rev"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:23:46Z","timestamp":1792689826000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0359945"}},"subtitle":[],"editor":[{"given":"Randy Wayne","family":"Bryner","sequence":"first","affiliation":[{"name":"West Virginia University","place":["UNITED STATES OF AMERICA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":18,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0359945","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]}}}